This small molecule research compound has been shown to reduce hyperglycemia in diabetic rat models. Its mechanism involves Akt-mediated upregulation of GLUT2 transporter expression in skeletal muscle and liver tissues, making it a candidate for investigating glucose metabolism pathways in both in vivo and in vitro experimental systems.
